QQQ   354.07 (-1.54%)
AAPL   172.24 (-2.18%)
MSFT   310.40 (-2.25%)
META   299.24 (-0.53%)
GOOGL   128.30 (-2.14%)
AMZN   125.72 (-4.23%)
TSLA   244.62 (-0.96%)
NVDA   419.71 (-0.59%)
NIO   8.41 (+0.72%)
BABA   85.96 (-1.44%)
AMD   95.66 (-1.77%)
T   15.04 (-0.13%)
F   12.45 (-1.03%)
MU   67.81 (-1.12%)
CGC   0.92 (-2.46%)
GE   110.08 (-1.47%)
DIS   80.16 (-1.05%)
AMC   7.97 (-2.09%)
PFE   32.57 (-1.24%)
PYPL   58.91 (+0.08%)
NFLX   378.29 (-1.69%)
QQQ   354.07 (-1.54%)
AAPL   172.24 (-2.18%)
MSFT   310.40 (-2.25%)
META   299.24 (-0.53%)
GOOGL   128.30 (-2.14%)
AMZN   125.72 (-4.23%)
TSLA   244.62 (-0.96%)
NVDA   419.71 (-0.59%)
NIO   8.41 (+0.72%)
BABA   85.96 (-1.44%)
AMD   95.66 (-1.77%)
T   15.04 (-0.13%)
F   12.45 (-1.03%)
MU   67.81 (-1.12%)
CGC   0.92 (-2.46%)
GE   110.08 (-1.47%)
DIS   80.16 (-1.05%)
AMC   7.97 (-2.09%)
PFE   32.57 (-1.24%)
PYPL   58.91 (+0.08%)
NFLX   378.29 (-1.69%)
QQQ   354.07 (-1.54%)
AAPL   172.24 (-2.18%)
MSFT   310.40 (-2.25%)
META   299.24 (-0.53%)
GOOGL   128.30 (-2.14%)
AMZN   125.72 (-4.23%)
TSLA   244.62 (-0.96%)
NVDA   419.71 (-0.59%)
NIO   8.41 (+0.72%)
BABA   85.96 (-1.44%)
AMD   95.66 (-1.77%)
T   15.04 (-0.13%)
F   12.45 (-1.03%)
MU   67.81 (-1.12%)
CGC   0.92 (-2.46%)
GE   110.08 (-1.47%)
DIS   80.16 (-1.05%)
AMC   7.97 (-2.09%)
PFE   32.57 (-1.24%)
PYPL   58.91 (+0.08%)
NFLX   378.29 (-1.69%)
QQQ   354.07 (-1.54%)
AAPL   172.24 (-2.18%)
MSFT   310.40 (-2.25%)
META   299.24 (-0.53%)
GOOGL   128.30 (-2.14%)
AMZN   125.72 (-4.23%)
TSLA   244.62 (-0.96%)
NVDA   419.71 (-0.59%)
NIO   8.41 (+0.72%)
BABA   85.96 (-1.44%)
AMD   95.66 (-1.77%)
T   15.04 (-0.13%)
F   12.45 (-1.03%)
MU   67.81 (-1.12%)
CGC   0.92 (-2.46%)
GE   110.08 (-1.47%)
DIS   80.16 (-1.05%)
AMC   7.97 (-2.09%)
PFE   32.57 (-1.24%)
PYPL   58.91 (+0.08%)
NFLX   378.29 (-1.69%)
NASDAQ:BCYC

Bicycle Therapeutics (BCYC) Insider Trading & Ownership

$20.17
+0.02 (+0.10%)
(As of 03:07 PM ET)
Compare
Today's Range
$20.09
▼
$21.12
50-Day Range
$20.09
▼
$25.82
52-Week Range
$18.84
▼
$33.49
Volume
110,297 shs
Average Volume
285,711 shs
Market Capitalization
$605.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$48.75
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Bicycle Therapeutics (NASDAQ:BCYC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$393,802.64
Get BCYC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bicycle Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BCYC Insider Buying and Selling by Quarter


Bicycle Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/3/2023Kevin LeeCEOSell1,498$25.10$37,599.80323,601  
7/3/2023Michael SkynnerCTOSell451$25.10$11,320.1070,924  
7/3/2023Nicholas KeenInsiderSell336$25.10$8,433.6038,505  
7/3/2023Travis Alvin ThompsonCAOSell61$25.10$1,531.108,033  
4/3/2023Kevin LeeCEOSell1,486$21.11$31,369.46325,099  
4/3/2023Lee KalowskiCFOSell376$21.11$7,937.3630,309  
4/3/2023Michael SkynnerCTOSell447$21.11$9,436.1771,375  
4/3/2023Nicholas KeenInsiderSell319$21.11$6,734.0938,841  
1/3/2023Kevin LeeCEOSell6,000$29.06$174,360.00326,585  
1/3/2023Lee KalowskiCFOSell1,815$29.06$52,743.9030,685  
1/3/2023Nigel CrockettInsiderSell1,801$29.06$52,337.0630,699  
(Data available from 1/1/2013 forward)












BCYC Insider Trading Activity - Frequently Asked Questions

Who is on Bicycle Therapeutics's Insider Roster?

The list of insiders at Bicycle Therapeutics includes Kate Bingham, Kevin Lee, Lee Kalowski, Michael Skynner, Nicholas Keen, Nigel Crockett, Pierre Legault, and Travis Alvin Thompson. Learn more on insiders at BCYC.

What percentage of Bicycle Therapeutics stock is owned by insiders?

10.20% of Bicycle Therapeutics stock is owned by insiders. Learn more on BCYC's insider holdings.

Which Bicycle Therapeutics insiders have been selling company stock?

The following insiders have sold BCYC shares in the last 24 months: Kevin Lee ($793,529.26), Lee Kalowski ($60,681.26), Michael Skynner ($20,756.27), Nicholas Keen ($15,167.69), Nigel Crockett ($52,337.06), Pierre Legault ($2,543,508.07), and Travis Alvin Thompson ($1,531.10).

How much insider selling is happening at Bicycle Therapeutics?

Insiders have sold a total of 68,807 Bicycle Therapeutics shares in the last 24 months for a total of $3,487,510.71 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:BCYC) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -